Phio Pharmaceuticals Corp. (PHIO)
NASDAQ: PHIO · Real-Time Price · USD
2.040
-0.020 (-0.97%)
At close: Sep 5, 2025, 4:00 PM
2.080
+0.040 (1.96%)
After-hours: Sep 5, 2025, 7:01 PM EDT

Phio Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
123251416
Upgrade
Market Cap Growth
254.92%67.92%-63.48%-62.43%-12.96%146.99%
Upgrade
Enterprise Value
1-2-6-9-13-1
Upgrade
Last Close Price
2.041.806.8440.18108.00290.52
Upgrade
Forward PE
-0.13-0.372.19-
Upgrade
PB Ratio
0.970.660.240.470.621.20
Upgrade
P/TBV Ratio
1.160.660.240.470.621.20
Upgrade
Debt / Equity Ratio
--0.010.020.010.05
Upgrade
Quick Ratio
8.935.305.206.087.846.49
Upgrade
Current Ratio
9.375.655.716.428.066.91
Upgrade
Return on Equity (ROE)
-102.18%-114.83%-116.60%-70.06%-76.04%-93.73%
Upgrade
Return on Assets (ROA)
-56.07%-61.14%-60.30%-37.72%-41.28%-46.22%
Upgrade
Return on Capital (ROIC)
-67.11%-73.94%-71.23%-43.11%-47.06%-55.16%
Upgrade
Earnings Yield
-60.65%-229.29%-582.98%-225.78%-98.17%-56.55%
Upgrade
FCF Yield
-61.16%-228.10%-579.10%-240.93%-87.99%-56.73%
Upgrade
Buyback Yield / Dilution
-590.92%-240.15%-83.32%-6.30%-179.70%-
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q